Literature DB >> 8747431

Proteolysis of synthetic peptides by type A botulinum neurotoxin.

J J Schmidt1, K A Bostian.   

Abstract

Type A botulinum neurotoxin catalyzed the hydrolysis of synthetic peptides based on the sequence of the 25-kD synaptosomal protein SNAP-25. In each peptide, the toxin cleaved at a single glutaminyl-arginine bond corresponding to residues 197 and 198 of SNAP-25, confirming earlier reports on the enzymatic specificity of the toxin in synaptosomal preparations. Metal chelators inhibited catalysis, consistent with a metalloprotease activity. In contrast to tetanus toxin and other botulinum toxin serotypes, type A toxin hydrolyzed relatively short, 17- to 20-residue peptides. In the substrates, SNAP-25 residue 202 and one or more of residues 187-191 were required for efficient hydrolysis, but residues 167-186 and 203-206 were not. The highest rates of hydrolysis were found when the C-terminal residues of the peptides were amidated.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747431     DOI: 10.1007/bf01886909

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  20 in total

1.  Identification of the nerve terminal targets of botulinum neurotoxin serotypes A, D, and E.

Authors:  G Schiavo; O Rossetto; S Catsicas; P Polverino de Laureto; B R DasGupta; F Benfenati; C Montecucco
Journal:  J Biol Chem       Date:  1993-11-15       Impact factor: 5.157

2.  Solid-phase synthesis, conformational analysis and in vitro cleavage of synthetic human synaptobrevin II 1-93 by tetanus toxin L chain.

Authors:  F Cornille; N Goudreau; D Ficheux; H Niemann; B P Roques
Journal:  Eur J Biochem       Date:  1994-05-15

3.  Clostridial neurotoxins: new tools for dissecting exocytosis.

Authors:  H Niemann; J Blasi; R Jahn
Journal:  Trends Cell Biol       Date:  1994-05       Impact factor: 20.808

Review 4.  Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release.

Authors:  G Schiavo; O Rossetto; C Montecucco
Journal:  Semin Cell Biol       Date:  1994-08

5.  Peptide substrate specificity and properties of the zinc-endopeptidase activity of botulinum type B neurotoxin.

Authors:  C C Shone; A K Roberts
Journal:  Eur J Biochem       Date:  1994-10-01

6.  The crystal structure of tris-inhibited phospholipase C from Bacillus cereus at 1.9 A resolution. The nature of the metal ion in site 2.

Authors:  S Hansen; L K Hansen; E Hough
Journal:  J Mol Biol       Date:  1993-06-05       Impact factor: 5.469

7.  SNARE motif and neurotoxins.

Authors:  O Rossetto; G Schiavo; C Montecucco; B Poulain; F Deloye; L Lozzi; C C Shone
Journal:  Nature       Date:  1994-12-01       Impact factor: 49.962

8.  The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations.

Authors:  G A Oyler; G A Higgins; R A Hart; E Battenberg; M Billingsley; F E Bloom; M C Wilson
Journal:  J Cell Biol       Date:  1989-12       Impact factor: 10.539

9.  Tetanus toxin is a zinc protein and its inhibition of neurotransmitter release and protease activity depend on zinc.

Authors:  G Schiavo; B Poulain; O Rossetto; F Benfenati; L Tauc; C Montecucco
Journal:  EMBO J       Date:  1992-10       Impact factor: 11.598

10.  Tetanus toxin: primary structure, expression in E. coli, and homology with botulinum toxins.

Authors:  U Eisel; W Jarausch; K Goretzki; A Henschen; J Engels; U Weller; M Hudel; E Habermann; H Niemann
Journal:  EMBO J       Date:  1986-10       Impact factor: 11.598

View more
  36 in total

1.  Comparison of extracellular and intracellular potency of botulinum neurotoxins.

Authors:  Fang Cai; Carrie B Adrion; James E Keller
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

Review 2.  The blockade of the neurotransmitter release apparatus by botulinum neurotoxins.

Authors:  Sergio Pantano; Cesare Montecucco
Journal:  Cell Mol Life Sci       Date:  2013-06-11       Impact factor: 9.261

3.  Substrates and controls for the quantitative detection of active botulinum neurotoxin in protease-containing samples.

Authors:  Karine Bagramyan; Bruce E Kaplan; Luisa W Cheng; Jasmin Strotmeier; Andreas Rummel; Markus Kalkum
Journal:  Anal Chem       Date:  2013-05-22       Impact factor: 6.986

4.  A chemotype that inhibits three unrelated pathogenic targets: the botulinum neurotoxin serotype A light chain, P. falciparum malaria, and the Ebola filovirus.

Authors:  Igor Opsenica; James C Burnett; Rick Gussio; Dejan Opsenica; Nina Todorović; Charlotte A Lanteri; Richard J Sciotti; Montip Gettayacamin; Nicoletta Basilico; Donatella Taramelli; Jonathan E Nuss; Laura Wanner; Rekha G Panchal; Bogdan A Solaja; Sina Bavari
Journal:  J Med Chem       Date:  2011-01-25       Impact factor: 7.446

5.  A high-throughput-compatible FRET-based platform for identification and characterization of botulinum neurotoxin light chain modulators.

Authors:  Dejan Caglič; Kristin M Bompiani; Michelle C Krutein; Petr Čapek; Tobin J Dickerson
Journal:  J Vis Exp       Date:  2013-12-27       Impact factor: 1.355

6.  Synthesis, characterization and development of a high-throughput methodology for the discovery of botulinum neurotoxin a inhibitors.

Authors:  Grant E Boldt; Jack P Kennedy; Mark S Hixon; Laura A McAllister; Joseph T Barbieri; Saul Tzipori; Kim D Janda
Journal:  J Comb Chem       Date:  2006 Jul-Aug

7.  Iterative structure-based peptide-like inhibitor design against the botulinum neurotoxin serotype A.

Authors:  Jorge E Zuniga; Jared T Hammill; Omri Drory; Jonathan E Nuss; James C Burnett; Rick Gussio; Peter Wipf; Sina Bavari; Axel T Brunger
Journal:  PLoS One       Date:  2010-06-30       Impact factor: 3.240

8.  Light chain separated from the rest of the type a botulinum neurotoxin molecule is the most catalytically active form.

Authors:  Nizamettin Gul; Leonard A Smith; S Ashraf Ahmed
Journal:  PLoS One       Date:  2010-09-22       Impact factor: 3.240

9.  Small molecule inhibitors of anthrax lethal factor toxin.

Authors:  John D Williams; Atiyya R Khan; Steven C Cardinale; Michelle M Butler; Terry L Bowlin; Norton P Peet
Journal:  Bioorg Med Chem       Date:  2013-11-13       Impact factor: 3.641

10.  Novel Benzimidazole Inhibitors of Botulinum Neurotoxin/A Display Enzyme and Cell-Based Potency.

Authors:  Steven C Cardinale; Michelle M Butler; Gordon Ruthel; Jonathan E Nuss; Laura M Wanner; Bing Li; Ramdas Pai; Norton P Peet; Sina Bavari; Terry L Bowlin
Journal:  Botulinum J       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.